AstraZeneca today announced that it plans to invest approximately $285 million in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that ...
Doctors turned powdered plastic into tiny devices that saved the lives of three baby boys by...
The company says it is tripling production of its new, fast-acting, inhalable insulin for...
The ruling could force several states to either find new execution drugs or change the way they put prisoners to death.
Bristol-Myers Squibb reported results for the first quarter of 2015, which were highlighted by strong global sales for key brands, important regulatory and clinical milestones and the completion of several strategic transactions.
This video showcases the precision engineering involved when GEA Pharma Systems, G-CON and Pfizer collaborated to develop modular, next generation processing technologies for oral solid dosage forms. The technology was recognized at last week's INTERPHEX with an Exhibitor Award.
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says research and consulting firm GlobalData.
Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.
NeoStem, Inc., a biopharmaceutical company developing novel cell-based individualized medicine therapies, announced today the expansion of manufacturing services under an existing Services Agreement between its wholly-owned subsidiary, PCT, and Kite Pharma.
Catalent Pharma Solutions announced the opening of a large scale expansion at its Winchester, KY, manufacturing facility.
International Pharmaceutical Expo, the premier industry event dedicated to showcasing pharmaceutical and biopharmaceutical innovation, technology and knowledge, today announced ACG North America will feature their line of end-to-end oral solid dosage manufacturing, packaging and inspection technologies, at INTERPHEX 2015.
GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of Rentschler’s biopharmaceutical manufacturing capabilities.
Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.
Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of ASEPCO Corporation (Asepco).
Merck's agreement with AIAC is to sell the manufacturing facility in Arecibo that was under closing plans. AIAC will retain the approximately 200 Merck employees.
Just as calibration needs to be part of your quality processes, it absolutely needs to be part of your asset performance management (APM) strategy as well.
Sampson and his three partners in Chicago-based Cresco Labs are switching livelihoods and risking millions of dollars to follow the promise of medical marijuana.
The cash payment under the Nektar-AstraZeneca agreement was triggered by the first commercial sale of MOVANTIK (naloxegol) in the U.S.
Cellceutix Corporation, a clinical stage biopharmaceutical company, has signed a $30 million stock purchase agreement with Aspire Capital Fund, LLC.
Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed.
Analyst Rob Goldman says mid-stage biotech companies are being built for potential sale, in an environment of increasing mergers and acquisitions.
Patheon has closed the transaction to acquire IRIX Pharmaceuticals, a company that specializes in making difficult to manufacture Active Pharmaceutical Ingredients (API).
Ajinomoto Althea announced today that it has added two more top pharmaceutical companies to its growing list of partners in developing and manufacturing cGMP-produced crystal-based drug products.
HHS awarded approximately $12 million today to BioCryst Pharmaceuticals of Durham, North Carolina, for the advanced development of a promising experimental drug for Ebola, including preparing for large-scale manufacturing of the drug and conducting related studies.
Actavis PLC is selling its generic drug business in Australia to privately-held Amneal Pharmaceuticals for an undisclosed amount.
Introducing a stainless steel version of the WLC60 heavy-duty LED lights, designed for use in extremely harsh conditions.
The MIT Center for Biomedical Innovation (CBI) announces a collaboration with the Amgen Foundation to develop the Amgen-MIT Biomanufacturing Educational Initiative, focused on biologics manufacturing.
A recently published market report indicates that the use of robots in a number of industries has more than tripled in the past five years and by 2018, robots are projected to be used for 27 percent of new line installations for medical device primary packaging. For the pharmaceutical industry, robots are expected to service 34 percent of primary packaging efforts, a 13 percent increase from 2013.
- Page 1